HS1BP3 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the HS1BP3 gene in the HEK293T host background. This heterogeneous pool of gene-edited cells provides a loss-of-function model that avoids the selection biases inherent in clonal isolation, enabling the study of HS1BP3 function in a population context. The polyclonal format is particularly suitable for probing the average effects of target-gene disruption on complex cellular processes such as actin remodeling and membrane trafficking.
HEK293T cells are a widely utilized human embryonic kidney epithelial cell line that constitutively expresses the SV40 large T antigen, facilitating high-level protein production and efficient lentiviral packaging. Their epithelial origin, rapid proliferation, and genetic tractability make them a robust platform for investigating signal transduction, cytoskeletal organization, and cell migration. These attributes allow for reliable comparisons between wild-type and HS1BP3 knockout populations in downstream assays.
HS1BP3 is a PX domain-containing protein that localizes to phosphoinositide-rich membrane microdomains and is proposed to orchestrate actin cytoskeleton dynamics. It acts downstream of receptor tyrosine kinases and small GTPases, including RAC1 and CDC42, and its membrane recruitment is influenced by PI3K-generated PIP3. HS1BP3 directly interacts with HS1 and SNX family proteins, and it is positioned to modulate the WAVE complex and ARP2/3-mediated actin nucleation, as well as cortactin-dependent branch stabilization. Target-gene disruption is therefore predicted to impair phosphoinositide-directed endocytosis, vesicle trafficking, and the formation of branched actin networks.
In the HEK293T epithelial context, which lacks the hematopoietic-specific interactor HS1, HS1BP3??s actin-regulatory functions can be examined in a simplified signaling environment. The polyclonal knockout population mitigates clonal variation and provides a stable, reproducible tool for measuring collective phenotypic alterations, such as changes in cell motility and endocytic uptake. This model is valuable for dissecting HS1BP3??s contributions to actin remodeling without confounding factors from lymphocytic signaling proteins.
These polyclonal knockout cells are compatible with a range of experimental approaches, including immunofluorescence microscopy for F-actin and focal adhesion visualization, wound healing assays to assess migration, and fluorescent ligand uptake assays to quantify endocytosis. Co-immunoprecipitation can be employed to identify altered protein complexes, and RT-qPCR can monitor transcriptional adjustments triggered by HS1BP3 loss. For detailed technical inquiries or custom applications, please contact Ascent Research.
